Nuclear Medicine Market: Introduction
Nuclear medicine imaging procedures are non-invasive and, except for intravenous injections, are generally painless medical tests that help doctors to diagnose and assess medical conditions. These imaging scans use radioactive materials called as radio pharmaceuticals or radio tracers.
As nuclear medicine procedures can identify molecular activity inside the body, they offer potential to identify disease at initial stages, as well as a patient’s instant response to therapeutic interventions.
Nuclear medicine or Radio pharmaceuticals is a division of medical imaging, which uses small quantities of radioactive material to analyse and determine severity of diseases, including cancers types, heart disease, gastrointestinal, endocrine, neurological disorders and other abnormalities within the body.
Get the Sample Report: https://bit.ly/2QeVSiQ
Nuclear Medicine Market: Analysis
The global nuclear medicine market has gained sustainable growth owing to increasing number of new cancer and cardiovascular cases, since nuclear medicines are used as a diagnostic tool for these diseases. Continuing research and studies demonstrating positive results is widening the scope of radioisotope applications for the diagnosis and treatment of bone diseases, respiratory diseases, thyroid-related diseases, and conditions of the digestive tract.
Along with applications, the radioisotopes are principally used in radiopharmacology to study drug movement in laboratory subjects. Moreover, need for early and accurate diagnostic methods coupled with growing demand for better therapies are fuelling the market growth. Furthermore, the overall market is also being propelled by the swiftly increasing demand generated from emerging countries. Improving medical infrastructure, growing expenditure on healthcare, and non-invasive nature of this procedure are some of the major factors responsible for this growth.
Browse for more: http://bit.ly/2Q8b6G9
Nuclear Medicine Market: By Geography
North America comprises United States, Canada and Mexico whereas Europe would primarily cover Germany, France, UK, Italy and Rest of Europe. The key countries included under Asia Pacific are China, Japan, India, Australia, and Rest of Asia Pacific. In Latin America, Brazil, Argentina, and Rest of Latin America are the key countries whereas in Middle East & Africa, South Africa and Rest of MEA are the key countries covered in the report.
Nuclear Medicine Market: Top Key Players
Some of the market players in the nuclear medicines include Bayer AG, Cardinal Health, Mallinckrodt PLC, GE Healthcare, Lantheus Medical Imaging, Inc., Bracco Imaging S.P.A, Eczacibasi-Monrol Nuclear Products, Nordion, Inc., Siemens Healthcare, Advanced Accelerator Applications S.A., Jubilant Pharma and among others.
Visit Our Company Profile: http://bit.ly/2Aud3Dz
Media Contact:
Ganesh Sai
616 Corporate Way, Suite 2-4268
Valley Cottage, NY, United States
Email: [email protected]
Tel: +1(845)875-9786, +44(0) 20 23869707